SmithKline Beecham R&D Chairman U'Prichard has drug discovery background from Zeneca and Nova.
Executive Summary
SMITHKLINE BEECHAM TURNING TO U'PRICHARD FOR R&D DIRECTION: effective Sept. 1, David U'Prichard, PhD, will assume the top R&D position at SB from a position as international director of research at Zeneca. U'Prichard, an 11-year Zeneca veteran, will report to SmithKline Beecham Pharmaceuticals Chief Operating Officer Jean Paul Garnier and will split his time between SB's dual headquarters in the U.S. and U.K.